| Literature DB >> 11728033 |
Abstract
We report on 2 recombinant (r) live vaccine candidates that use different strategies to improve cell-mediated immunity for TB control: (i) the current TB vaccine strain Mycobacterium bovis BCG, endowed with a pore-forming cytolysin; and (ii) rSalmonella typhimurium secreting a single immunodominant antigen shared by BCG and M. tuberculosis.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11728033 DOI： 10.1080/003655401317074473
Source DB: PubMed Journal: Scand J Infect Dis ISSN： 0036-5548